Metabolic syndrome prevalence in the town of Arjona, Colombia;Prevalencia de síndrome metabólico en el municipio de arjona, colombia

Revista Colombiana de Cardiologia

Volumn 15, Issue 5, 2008, Pages 215-222

  Manzur, Fernando ^a   de la Ossa, Martín ^a   Trespalacios, Erik ^a   Abuabara, Yasmín ^a   Lujan, Marcos ^a  

^a UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Arterial hypertension; Diabetes mellitus; Dyslipidemia; Metabolic syndrome; Prevalence

Indexed keywords

EID: 84856239976     PISSN: 01205633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. López-Jaramillo P, Silva S, Ramírez F, García R. Síndrome metabólico: diagnóstico y prevención. Acta Med Colomb 2004; 29 (3): 137-144.
2. Instituto Colombiano de Bienestar Familiar. Encuesta Nacional de la Situación Nutricional en Colombia. Disponible en: www.icbf.gov.co. 2005.
3. Lakka Hm, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Isomaa B, et al. Cardiovascular morbity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
5. Executive Summary of The Third Report of the National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
6. Ford ES, et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
7. Ford ES, et al. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin Am 2004; 33: 333-350.
8. Soto V, et al. Prevalencia y factores de riesgo de síndrome metabólico en población adulta del departamento de Lambayeque, Perú - 2004. Rev Peru Med Exp Salud Publica 2005; 22 (4).
9. Piombo A, et al. Prevalencia, características y valor pronóstico del síndrome metabólico en los síndromes coronarios agudos. Rev Argent Cardiol 2005; 73: 424-428.
10. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Vissersen FL, for the SMART Study Group: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342-8.
11. Aschner Chávez M, Izquierdo J, Sole J, Tarazona A, Pinzón JB, et al. Prevalence of the metabolic syndrome in a rural and urban population in Colombia. Diab Res Clin Prac 2002; 57 (Suppl 1): 532.
12. Villegas A, et al. Prevalencia de síndrome metabólico en El Retiro, Colombia. IATREIA 2003; 16: 291-297.
13. Lombo B et al. Prevalencia del síndrome metabólico entre los pacientes que asisten al servicio Clínica de Hipertensión de la Fundación Santa Fe de Bogotá. Rev Col Cardiol 2006; 12: 472-478.
14. Alayón A, Alvear C. Prevalencia de desórdenes del metabolismo de los glúcidos y perfil del diabético en Cartagena de Indias (Colombia), 2005. Salud Uninorte 2006; 22 (1): 20-28.
15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112 (17): 2735-2752.
16. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-47.
17. Grundy S. Does a diagnosis of metabolic syndrome have value in clinical. practice? Am J Clin Nutr 2006; 83: 1248-51.
18. Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.
19. Eric B. Loucks E, et al. Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol 2007; 17: 19-26.
20. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP criteria. Diabetes Res Clin Pract 2003; 60: 199-204.
21. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract 2003; 61: 29-37.
22. Nakanishi N, Nishina K, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, et al. Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers. Diabetes Res Clin Pract 2004; 63: 185-94.
23. Jeannette Lee, Stefan MA, Derrick Heng, Chee-Eng Tan, et al. Should central obesity be an optional or essential component of the metabolic syndrome? Diabetes Care 2007; 30: 343-347.
24. Lombo B et al. Prevalencia del síndrome metabólico en pacientes diabéticos. Acta Med Colomb 2007; 32: 9-15.
25. Alegria E, et al. Prevalencia del síndrome metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol 2005; 58 (7): 797-806.
26. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404-409.
27. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB, Williams K, Haffner SM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring studies. Diabetes 2003; 52: 2160-7.
28. Carr M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-2411.
29. López-Jaramillo P, et al. Patología socioeconómica como causa de las diferencias regionales en las prevalencias de síndrome metabólico e hipertensión inducida por el embarazo. Rev Esp Cardiol 2007; 60 (2): 168-78.